News

Mr Warren assumes the office from Mitchell Dann who has served as interim CEO since February 2008. Mr Dann continues to serve as chairman and a director. From

James Miller, president and CEO of Pinnacle Biologics, said: “The completion of the Chiltern agreement represents a significant step in the process of offering a full range of

Laboratorios Casen-Fleet, the Spanish affiliate of the US healthcare company Fleet Laboratories, has recently acquired the red clover isoflavone-based menopause product Fitogyn from Laboratorios Gynea. In conjunction with

According to the company, the new 96-well kit is suitable for a variety of pharmaceutical and biotechnology research applications, providing rapid purification of plasmid DNA that can generate

The study, required by the FDA for all new chemical entities, was conducted to evaluate the cardiac safety of TZP-101, with a focus on cardiac repolarization as measured

The objective of this research is to make surgery for brain tumors and inflammatory lesions simpler and more precise by using fluorescent nanospheres to more easily visualize tumors

The oral solution formulation, which is a new dosage form of Aptivus, was also approved for treatment-experienced adults. The oral solution formulation will be available in the US

The study will include a maximum of 36 patients who are ineligible for platinum based chemotherapy. In the dose-escalation part of the study, six to 24 patients will

The initial results from this proof of concept study showed activity of lacosamide in fibromyalgia syndrome but require further analysis. A decision to start Phase IIb will be